Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01248065 · ClinicalTrials.gov registry record · Phase 3
Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 408
- Enrollment target
NCT01248065 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 408 participants.
The verdict
NCT01248065, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 408 participants
- Enrollment target
Study Summary
The purpose of the study is to find out if taking vitamin D in addition to an asthma controller medication helps to prevent worsening of asthma symptoms and asthma attacks.
Interventions
- DRUG Vitamin D3
- DRUG Ciclesonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01248065
The ClinicalTrials.gov registry entry for NCT01248065 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 is the first listed.
NCT01248065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01248065 about?
NCT01248065 is a clinical study titled "Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma". The purpose of the study is to find out if taking vitamin D in addition to an asthma controller medication helps to prevent worsening of asthma symptoms and asthma attacks.
What is the current status of trial NCT01248065?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 408 participants. The study started on 2011-04. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01248065?
The interventions under investigation include: Vitamin D3 (DRUG), Ciclesonide (DRUG).
Who is sponsoring clinical trial NCT01248065?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.